Stockscreener 앱 받기
2.72
3.42%
0.09
시간 외 거래:
2.90
0.18
+6.62%
전일 마감가:
$2.63
열려 있는:
$2.76
하루 거래량:
55,398
Relative Volume:
1.02
시가총액:
$26.14M
수익:
$442.00K
순이익/손실:
$-30.46M
주가수익비율:
-0.6099
EPS:
-4.46
순현금흐름:
$-27.47M
1주 성능:
-6.53%
1개월 성능:
-10.23%
6개월 성능:
-48.68%
1년 성능:
-64.81%
1일 변동 폭
$2.5999
$2.7987
1주일 범위
$2.55
$2.93
52주 변동 폭
$2.55
$9.20
Clene Inc Stock (CLNN) Company Profile
명칭
Clene Inc
전화
801-676-9695
주소
6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY
CLNN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CLNN
Clene Inc
|
2.72 | 26.14M | 442.00K | -30.46M | -27.47M | -4.46 |
|
KHC
Kraft Heinz Co
|
28.15 | 33.84B | 25.43B | 2.66B | 3.03B | 2.19 |
|
GIS
General Mills Inc
|
54.84 | 30.15B | 19.64B | 2.56B | 2.48B | 4.55 |
|
K
Kellanova
|
82.30 | 28.66B | 12.63B | 1.38B | 863.00M | 3.96 |
|
MKC
Mccormick Co Inc
|
76.49 | 20.19B | 6.68B | 792.60M | 774.40M | 2.94 |
|
HRL
Hormel Foods Corp
|
29.55 | 16.06B | 11.92B | 805.04M | 1.01B | 1.46 |
Clene Inc Stock (CLNN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-10-04 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2022-07-18 | 개시 | H.C. Wainwright | Buy |
| 2022-05-02 | 개시 | Canaccord Genuity | Buy |
| 2021-09-28 | 개시 | Oppenheimer | Outperform |
Clene Inc 주식(CLNN)의 최신 뉴스
HC Wainwright Issues Positive Forecast for Clene Earnings - Defense World
Roth Capital Has Optimistic Outlook of Clene Q2 Earnings - Defense World
Benchmark Lowers Clene (NASDAQ:CLNN) Price Target to $33.00 - Defense World
D. Boral Capital Reaffirms Buy Rating for Clene (NASDAQ:CLNN) - Defense World
Clene Inc. Reports Reduced Losses Amid Strategic Cost-Saving Measures - TipRanks
Clene Inc. Advances CNM-Au8 Treatment for ALS, Reports Promising Q1 Results - citybuzz -
Clene Inc. Advances CNM-Au8 Toward Potential Accelerated Approval for ALS - citybuzz -
Clene’s Strategic Financial Management and Promising Clinical Developments Drive Buy Rating - TipRanks
Clene (CLNN) Maintains Buy Rating Despite Price Target Reduction - GuruFocus
Clene (CLNN) Stock Rating and Price Target Maintained at Buy | CLNN Stock News - GuruFocus
Renaissance Technologies LLC Invests $96,000 in Clene Inc. (NASDAQ:CLNN) - Defense World
Clene Inc. to Showcase Neurodegenerative Research at D. Boral Capital Global Conference - citybuzz -
Clene Inc. (CLNN) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
Clene (CLNN) Reports Decline in Cash Reserves | CLNN Stock News - GuruFocus
Clene Faces Nasdaq Delisting Risk Amid Regulatory Pursuits - TipRanks
Clene (CLNN) Exceeds Revenue Expectations and Advances ALS Research | CLNN Stock News - GuruFocus
Clene Reports First Quarter 2025 Financial Results and Recent Operating Highlights - The Manila Times
Clene Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference | CLNN Stock News - GuruFocus
Clene Inc. SEC 10-Q Report - TradingView
Clene Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference - The Kingston Whig Standard
Geode Capital Management LLC Grows Stake in Clene Inc. (NASDAQ:CLNN) - Defense World
Clene Inc. expected to post a loss of 95 cents a shareEarnings Preview - TradingView
Clene Inc. Enters Agreement for $25M Equity Distribution By Investing.com - Investing.com Nigeria
Clene Inc. Enters Agreement for $25M Equity Distribution - Investing.com Australia
Clene Inc.Enters Equity Distribution Agreement With CanaccordSEC Filing - marketscreener.com
Analysts Set Clene Inc. (NASDAQ:CLNN) Target Price at $55.25 - Defense World
Clene (NASDAQ:CLNN) Research Coverage Started at Jones Trading - Defense World
Clene (CLNN) Receives Buy Rating and $30 Target from JonesResear - GuruFocus
Clene (CLNN) Receives Buy Rating and $30 Target from JonesResearch | CLNN Stock News - GuruFocus
Clene to Present at the Emerging Growth Conference | CLNN Stock News - GuruFocus
Nanomedicines Market to Witness Massive Growth by 2032 | Abbott - openPR.com
Clene to Present at the Emerging Growth Conference - The Manila Times
Clene’s (CLNN) “Buy” Rating Reiterated at D. Boral Capital - Defense World
Nanomedicines Market Generated Opportunities, Future Scope 2025-2032 | Abbott, CombiMatrix, Clene Nanomedicine - newstrail.com
Clene’s (CLNN) Buy Rating Reiterated at HC Wainwright - Defense World
Clene reports MS patient improvements with CNM-Au8 treatment By Investing.com - Investing.com India
Clene announces evidence of remyelination, neuronal repair with CNM-Au8 - TipRanks
Clene reports MS patient improvements with CNM-Au8 treatment - Investing.com Australia
Clene (NASDAQ: CLNN) to Present at Jones Healthcare and Technology Innovation Conference - The Globe and Mail
CLNN stock touches 52-week low at $2.95 amid market challenges By Investing.com - Investing.com South Africa
CLNN stock touches 52-week low at $2.95 amid market challenges - Investing.com India
Clene to Present at the Jones Healthcare and Technology Innovation Conference - The Manila Times
Clene Reveals Latest ALS and MS Treatment Innovations at Major Healthcare Conference - Stock Titan
Promising Nanotechnology Stocks To ResearchMarch 29th - MarketBeat
Roth Capital Has Negative Estimate for Clene Q1 Earnings - Defense World
Clene Inc. settles debt with equity issuance - Investing.com
Clene Inc.'S (NASDAQ: CLNN) Q1 Virtual Investor Summit Presentation Available For On-Demand Viewing - MENAFN.COM
Roth Capital Has Optimistic Outlook of Clene FY2027 Earnings - Defense World
Research Analysts Issue Forecasts for Clene Q1 Earnings - Defense World
Clene (NASDAQ:CLNN) Earns Buy Rating from D. Boral Capital - The AM Reporter
What is HC Wainwright’s Estimate for Clene FY2028 Earnings? - Defense World
Clene Inc (CLNN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
7.21%
1.61%
자본화:
|
볼륨(24시간):